It is a healthcare private limited company based in Nellore, Andhra Pradesh, India, established in 2016.
2016 | Nellore, Andhra Pradesh, India | Struck OffNellore Oncology Consortium Private Limited, a struck off private limited company, was established on 22 September 2016 in Nellore, Andhra Pradesh, India. Engaging in hospital services within the hospital and medical care sector, it holds CIN: U85300AP2016PTC104126. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Ramesh Maturi (Director), Shankar Vangipuram Radha Krishna Gowri (Director), Haritha Chiramana (Director). Past directors included Annam Sharath, Anil Krishna Gundala. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 17-2-163 Kavita Nursing Home Opposite Bsnl Office, Leela Mahal Center, Nellore, Andhra Pradesh, 524003.
U85300AP2016PTC104126
104126
22 September 2016
₹1.50 M
₹1.50 M
Roc Vijayawada
Unlisted
Struck Off
Explore comprehensive insights into Nellore Oncology Consortium Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Maturi | Director | 22 Sep 2016 | Current |
| Shankar Vangipuram Radha Krishna Gowri | Director | 22 Sep 2016 | Current |
| Haritha Chiramana | Director | 24 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Jan 2020 | Past |
| Pramod Abcsdd | Additional Director | 24 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nellore Oncology Consortium Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Nellore Oncology Consortium had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nellore Oncology Consortium, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nellore Oncology Consortium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nellore Oncology Consortium's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nellore Oncology Consortium Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Nellore Oncology Consortium Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Vijayawada. was completed.
The activity Haritha Chiramana was appointed as a Director was appointed as a Director on 24 Jun 2017 & has been associated with this company since 8 years 6 months . was completed.
Ramesh Maturi was appointed as a Director was appointed as a Director on 22 Sep 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
The activity Shankar Vangipuram Radha Krishna Gowri was appointed as a Director was appointed as a Director on 22 Sep 2016 & has been associated with this company since 9 years 3 months . was completed.
The activity Nellore Oncology Consortium Private Limited was registered on 22 Sep 2016 with Roc Vijayawada & aged 9 years 3 months as per MCA records. was completed.
The CIN of Nellore Oncology Consortium Private Limited is U85300AP2016PTC104126.
Nellore Oncology Consortium Private Limited is headquartered at 17-2-163 Kavita Nursing Home Opposite Bsnl Office, Leela Mahal Center, Nellore, Andhra Pradesh, 524003.
Nellore Oncology Consortium Private Limited was incorporated on 22 September 2016.
The current directors of Nellore Oncology Consortium Private Limited are
The primary industry of Nellore Oncology Consortium Private Limited is Hospital And Medical Care.
Nellore Oncology Consortium Private Limited is unlisted.
The authorized capital of Nellore Oncology Consortium Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Nellore Oncology Consortium Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX